Latest filing published 26 Aug 2026 for CENTENE CORP, €2.4M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Burdick Kenneth A across 2 companies, led by Centene Corp and LifeStance Health Group, Inc. In total, 4 filings cover trades dated from 10 June 2026 to 26 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 26 August 2026 came the latest disclosure, a transaction for €2.4M in Centene Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations